U.K. Biotechnology Reagents & Kits Market Size & Outlook
The biotechnology reagents & kits market in the UK is expected to reach a projected revenue of US$ 58.8 billion by 2028. A compound annual growth rate of 16% is expected of the UK biotechnology reagents & kits market from 2021 to 2028.
Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd
Other key industry trends
In terms of revenue, UK accounted for 5.3% of the global biotechnology reagents & kits market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
In Europe, UK biotechnology reagents & kits market is projected to lead the regional market in terms of revenue in 2028.
Spain is the fastest growing regional market in Europe and is projected to reach USD 25.0 billion by 2028.
Growing research on life sciences is driving the UK market. Brexit was expected to impede research in the country, but its contribution in the life sciences domain remains stable. For the 50th year, the UK has continued as the second largest researcher in life sciences.
The country has top institutes, such as the University of Oxford, the University of Cambridge, and Imperial College London, which are key users of kits & reagents. The Oxford biotech cluster supported by the Oxford Biotech Network carries out a broad range of projects, from regular drug discovery & development to research on innovative medical technology.
For instance, in February 2021, CPI declared the launch of a project in Medicine Developing Innovation Center that is focused on revolutionize manufacturing of oligonucleotides, by collaboration with Novartis, AstraZeneca, UK Research & innovation, and Exactmer.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biotechnology Reagents & Kits Market Outlook will help companies and investors design strategic landscapes.
Detection Kits was the largest segment with a revenue share of 22.91% in 2020.
Horizon Databook has segmented the U.K. biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Growing research on life sciences is driving the UK market. Brexit was expected to impede research in the country, but its contribution in the life sciences domain remains stable. For the 50th year, the UK has continued as the second largest researcher in life sciences.
The country has top institutes, such as the University of Oxford, the University of Cambridge, and Imperial College London, which are key users of kits & reagents. The Oxford biotech cluster supported by the Oxford Biotech Network carries out a broad range of projects, from regular drug discovery & development to research on innovative medical technology.
For instance, in February 2021, CPI declared the launch of a project in Medicine Developing Innovation Center that is focused on revolutionize manufacturing of oligonucleotides, by collaboration with Novartis, AstraZeneca, UK Research & innovation, and Exactmer.
U.K. Biotechnology Reagents & Kits Market Kit Type Outlook (Revenue, USD BIllion , 2018-2028)
Reasons to subscribe to Biotechnology Reagents & Kits Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biotechnology Reagents & Kits Market Outlook databook
Our clientele includes a mix of Biotechnology Reagents & Kits Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Biotechnology Reagents & Kits Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Biotechnology Reagents & Kits Market Outlook from 2018 to 2028, including revenue numbers, major trends, and company profiles.